drugset / Trial / NCT01554813
Clinical Trial of Inactivated Influenza Vaccine (0.5ml Formulation)
RandomizedParallel-groupSingle-blindPrevention
Summary
The clinical trial was conducted in Jintan City of Jiangsu Province, China in May, 2006. The purpose of the clinical trial was to evaluate the safety and immunogenicity against Hualan's Influenza Vaccine (Split Virion), Inactivated (0.5ml) administered on age 6 months and old population.
Timeline
- Start
- 2006-05
- Primary completion
- 2006-07
- Completion
- 2006-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Inactivated Influenza Vaccine (Split Virion) | Vaccine | 15 ug | — |
| Comparator | Inactivated Influenza Vaccine (Split Virion) | Vaccine | 0.5 ml | — |